Andreas Port
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
Papers in
-
- Renal Transplantation Outcomes and Treatments 2
-
- Cholinesterase and Neurodegenerative Diseases 2
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Arne Ring (3 shared papers)Christian Friedrich (2 shared papers)Ulrike Graefe‐Mody (2 shared papers)Atef Halabi (1 shared paper)Tim Heise (1 shared paper)H.J. Woerle (1 shared paper)Silke Retlich (1 shared paper)John M. Kovarik (3 shared papers)
- Journals
- Annals of Pharmacotherapy (2 papers)The Journal of Clinical Pharmacology (2 papers)British Journal of Clinical Pharmacology (1 paper)Pharmacology Research & Perspectives (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Andreas Port
14 papers receiving 435 citations
Peers
Comparison fields: 5 of 65
- Endocrinology, Diabetes and Metabolism 219
- Transplantation 27
- Pharmacology 52
- Pharmacology 25
- Oncology 69
Countries citing papers authored by Andreas Port
This map shows the geographic impact of Andreas Port's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Port with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Port more than expected).
Fields of papers citing papers by Andreas Port
This network shows the impact of papers produced by Andreas Port. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Port. The network helps show where Andreas Port may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Port, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 155 | |
| 2 | 2002 | 68 | |
| 3 | 2021 | 46 | |
| 4 | 2007 | 41 | |
| 5 | 2005 | 39 | |
| 6 | 2011 | 27 | |
| 7 | 2001 | 23 | |
| 8 | 2011 | 23 | |
| 9 | 2001 | 19 | |
| 10 | 2021 | 15 | |
| 11 | 2002 | 3 | |
| 12 | 2009 | 3 | |
| 13 | 2020 | 1 | |
| 14 | 2021 | 1 |
About Andreas Port
Andreas Port is a scholar working on Transplantation, Pharmacology, Pharmacology, Analytical Chemistry and Endocrinology, Diabetes and Metabolism, having authored 14 papers that have together received 464 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Immune Response and Inflammation (2 papers), Receptor Mechanisms and Signaling (2 papers), Phosphodiesterase function and regulation (2 papers) and Diabetes Treatment and Management (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (219 citations), Transplantation (27 citations), Pharmacology (52 citations), Pharmacology (25 citations) and Oncology (69 citations). Andreas Port has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Arne Ring, Christian Friedrich, Ulrike Graefe‐Mody, Atef Halabi, Tim Heise, H.J. Woerle, Silke Retlich, John M. Kovarik, Stefan Hartmann and Christiane M Rordorf. Their work appears in journals such as Annals of Pharmacotherapy, The Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, Pharmacology Research & Perspectives and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.